Advertisement
OtherMinireview

Absorption, distribution, metabolism, and excretion of FDA-approved antisense oligonucleotide drugs

Julia M Migliorati, Sunna Liu, Anna Liu, Anagha Gogate, Sreenidhi Nair, Raman Bahal, Theodore P Rasmussen, Jose E. Manautou PhD and Xiao-bo Zhong
Drug Metabolism and Disposition February 27, 2022, DMD-MR-2021-000417; DOI: https://doi.org/10.1124/dmd.121.000417
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

OtherMinireview

ADME of FDA-approved ASO drugs

Julia M Migliorati, Sunna Liu, Anna Liu, Anagha Gogate, Sreenidhi Nair, Raman Bahal, Theodore P Rasmussen, Jose E. Manautou and Xiao-bo Zhong
Drug Metabolism and Disposition February 27, 2022, DMD-MR-2021-000417; DOI: https://doi.org/10.1124/dmd.121.000417
Reddit logo Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement